Cargando…
The role of MET in chemotherapy resistance
Chemotherapy remains the mainstay of treatment in the majority of solid and haematological malignancies. Resistance to cytotoxic chemotherapy is a major clinical problem and substantial research is ongoing into potential methods of overcoming this resistance. One major target, the receptor tyrosine...
Autores principales: | Wood, Georgina E., Hockings, Helen, Hilton, Danielle M., Kermorgant, Stéphanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979538/ https://www.ncbi.nlm.nih.gov/pubmed/33526881 http://dx.doi.org/10.1038/s41388-020-01577-5 |
Ejemplares similares
-
The Role of PI3K in Met Driven Cancer: A Recap
por: Hervieu, Alexia, et al.
Publicado: (2018) -
Unconventional role of RAC1 in MET-driven anchorage-independent tumor growth
por: Hervieu, Alexia, et al.
Publicado: (2020) -
The clinical and functional significance of c-Met in breast cancer: a review
por: Ho-Yen, Colan M, et al.
Publicado: (2015) -
c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
por: Stanislovas, Justas, et al.
Publicado: (2022) -
Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation
por: Kermorgant, Stéphanie, et al.
Publicado: (2008)